Clinical trial
CoMBo Study: Contingency Management for Both HIV And Stimulant Use in Primary Care
NCT06564792 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CoMBo Study: Contingency Management for Both HIV And Stimulant Use in Primary Care
- Lead sponsor
- University of California, San Francisco
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 15, 2023
- Completion date
- October 1, 2025
- Enrollment
- 37 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hiv, stimulant use (diagnosis)